
Coherence Bio provides an automated platform that enables rapid, in-house detection of viruses and bacteria to shorten pathogen testing timelines. The company combines compact, AI-integrated lab automation with cell-based assays to replace slow, manual validation and accelerate biological testing. Its product is positioned as a hardware-plus-software lab automation solution for research and clinical laboratories that need fast, repeatable cell-based readouts. Coherence Bio emphasizes plug-and-play instruments that close the loop between AI models and wet-lab experiments to support iterative discovery and testing. The platform targets labs seeking to bring high-throughput, AI-driven pathogen detection and cell-based validation in-house.

Coherence Bio provides an automated platform that enables rapid, in-house detection of viruses and bacteria to shorten pathogen testing timelines. The company combines compact, AI-integrated lab automation with cell-based assays to replace slow, manual validation and accelerate biological testing. Its product is positioned as a hardware-plus-software lab automation solution for research and clinical laboratories that need fast, repeatable cell-based readouts. Coherence Bio emphasizes plug-and-play instruments that close the loop between AI models and wet-lab experiments to support iterative discovery and testing. The platform targets labs seeking to bring high-throughput, AI-driven pathogen detection and cell-based validation in-house.